Caricamento...
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy
BACKGROUND AND PURPOSE: KRAS and BRAF are mutated in 35% and 10% of colorectal cancers, respectively. However, data specifically for locally advanced rectal cancers are scarce, and the frequency of KRAS mutations in codons 61 and 146 remains to be established. MATERIALS AND METHODS: DNA was isolated...
Salvato in:
| Pubblicato in: | Radiother Oncol |
|---|---|
| Autori principali: | , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373270/ https://ncbi.nlm.nih.gov/pubmed/19913317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2009.10.001 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|